EMD Millipore and Samsung BioLogics signed a Memorandum of Understanding (MOU) for a strategic alliance to encompass a long-term supply agreement.
Udit Batra, Ph.D., told GEN, his company is working to shorten the supply chain and unclog other bottlenecks to CAR-T development besides vector supply.
Companies believe that the alliance will enable technology improvements and better efficiencies.
Vaccine is reportedly the first in which gene customization has been used successfully to control virulence in bacteria.
The buyer, Dutch generics giant Aspen Group, looks to broaden offerings, global operations
Enhanced cleanroom is key feature. Gore PharmBIO Products opened a new manufacturing facility, which doubles its capacity. Located in Elkton, MD, the site will house a cleanroom that is designed to be more efficient and...
Engineered tumor cells trigger T-cell responses that protect against subsequent tumor cell challenge.
Please wait while you are redirected to the right page...